513 related articles for article (PubMed ID: 11204503)
21. Visceral leishmaniasis and HIV in Tigray, Ethiopia.
Lyons S; Veeken H; Long J
Trop Med Int Health; 2003 Aug; 8(8):733-9. PubMed ID: 12869095
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears.
Martínez P; de la Vega E; Laguna F; Soriano V; Puente S; Moreno V; Sentchordi MJ; García-Aguado C; González-Lahoz J
AIDS; 1993 Feb; 7(2):227-30. PubMed ID: 8466685
[TBL] [Abstract][Full Text] [Related]
23. A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy.
Houghton RL; Petrescu M; Benson DR; Skeiky YA; Scalone A; Badaró R; Reed SG; Gradoni L
J Infect Dis; 1998 May; 177(5):1339-44. PubMed ID: 9593022
[TBL] [Abstract][Full Text] [Related]
24. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
25. Visceral leishmaniasis diagnosed by colonoscopy.
Sebastián JJ; García S; Soria MT; Pac J; Vicente J; Uribarrena R
J Clin Gastroenterol; 1997 Dec; 25(4):691-2. PubMed ID: 9451690
[TBL] [Abstract][Full Text] [Related]
26. [Visceral Leishmaniasis in HIV-Infected Patients: The Challenge of Relapse and Treatment Failure].
Cipriano P; Miranda AC; Antunes I; Mansinho K
Acta Med Port; 2017 Jun; 30(6):443-448. PubMed ID: 28898610
[TBL] [Abstract][Full Text] [Related]
27. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
Ali A
Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
[TBL] [Abstract][Full Text] [Related]
28. [Visceral leishmaniasis associated with human immunodeficiency virus infection].
Pintado V; López-Vélez R
Enferm Infecc Microbiol Clin; 2001; 19(7):353-7. PubMed ID: 11747803
[No Abstract] [Full Text] [Related]
29. Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis.
Bosch RJ; Rodrigo AB; Sánchez P; de Gálvez MV; Herrera E
Int J Dermatol; 2002 Oct; 41(10):670-5. PubMed ID: 12390190
[TBL] [Abstract][Full Text] [Related]
30. Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy.
Peters BS; Fish D; Golden R; Evans DA; Bryceson AD; Pinching AJ
Q J Med; 1990 Nov; 77(283):1101-11. PubMed ID: 2274656
[TBL] [Abstract][Full Text] [Related]
31. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.
Cota GF; de Sousa MR; de Mendonça AL; Patrocinio A; Assunção LS; de Faria SR; Rabello A
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2816. PubMed ID: 24743472
[TBL] [Abstract][Full Text] [Related]
32. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
[TBL] [Abstract][Full Text] [Related]
33. Pre- & post-treatment evaluation of immunological features in Indian visceral leishmaniasis (VL) patients with HIV co-infection.
Sinha PK; Bimal S; Singh SK; Pandey K; Gangopadhyay DN; Bhattacharya SK
Indian J Med Res; 2006 Mar; 123(3):197-202. PubMed ID: 16778304
[TBL] [Abstract][Full Text] [Related]
34. Parasitic culture of buffy coat for diagnosis of visceral leishmaniasis in human immunodeficiency virus-infected patients.
López-Vélez R; Laguna F; Alvar J; Pérez-Molina JA; Molina R; Martinez P; Villarrubia J
J Clin Microbiol; 1995 Apr; 33(4):937-9. PubMed ID: 7790464
[TBL] [Abstract][Full Text] [Related]
35. Visceral leishmaniasis with pericarditis in an HIV-infected patient.
Mofredj A; Guerin JM; Leibinger F; Masmoudi R
Scand J Infect Dis; 2002; 34(2):151-3. PubMed ID: 11928856
[TBL] [Abstract][Full Text] [Related]
36. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.
Russo R; Laguna F; López-Vélez R; Medrano FJ; Rosenthal E; Cacopardo B; Nigro L
Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():99-105. PubMed ID: 14678637
[TBL] [Abstract][Full Text] [Related]
37. Visceral Leishmaniasis/HIV co-infection in northeast Brazil: evaluation of outcome.
Távora LG; Nogueira MB; Gomes ST
Braz J Infect Dis; 2015; 19(6):651-6. PubMed ID: 26361839
[TBL] [Abstract][Full Text] [Related]
38. [The incidence, etiology and clinical significance of visceral mycoses in patients with AIDS].
Manfredi R; Nanetti A; Mazzoni A; Mastroianni A; Chiodo F
Minerva Med; 1993; 84(7-8):383-91. PubMed ID: 8414130
[TBL] [Abstract][Full Text] [Related]
39. HIV/AIDS-related visceral leishmaniasis: a clinical and epidemiological description of visceral leishmaniasis in northern Brazil.
Albuquerque LC; Mendonça IR; Cardoso PN; Baldaçara LR; Borges MR; Borges Jda C; Pranchevicius MC
Rev Soc Bras Med Trop; 2014; 47(1):38-46. PubMed ID: 24603735
[TBL] [Abstract][Full Text] [Related]
40. Visceral leishmaniasis in patients infected with the human immunodeficiency virus.
Laguna F; Adrados M; Alvar J; Soriano V; Valencia ME; Moreno V; Polo R; Verdejo J; Jiménez MI; Martínez P; Martínez ML; González-Lahoz JM
Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):898-903. PubMed ID: 9495670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
